avelumab

Trials studying avelumab

• —JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Studycompletedn=360
• phase2Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancerrecruitingn=159
• phase2A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)active not recruitingn=256
• phase3Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)active not recruitingn=956
• phase2Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Canceractive not recruitingn=145
• phase2DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinomarecruitingn=25
• phase3Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closingactive not recruitingn=68
• phase3Adjuvant Avelumab in Merkel Cell Canceractive not recruitingn=101